Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Testosterone
Drug ID BADD_D02170
Description Testosterone is a steroid sex hormone indicated to treat primary hypogonadism and hypogonadotropic hypogonadism.[L8983,L8935,L8938,L8986,L8989,L8992,L8995] Testosterone antagonizes the androgen receptor to induce gene expression that causes the growth and development of masculine sex organs and secondary sexual characteristics.[A187114,L8983,L8935,L8938,L8986,L8989,L8992,L8995] Testosterone was isolated from samples and also synthesized in 1935.[A186943]
Indications and Usage Testosterone is indicated to treat primary hypogonadism and hypogonadotropic hypogonadism.[L8983,L8935,L8938,L8986,L8989,L8992,L8995]
Marketing Status approved; investigational
ATC Code G03BA03
DrugBank ID DB00624
KEGG ID D00075
MeSH ID D013739
PubChem ID 6013
TTD Drug ID D06XMU
NDC Product Code 0832-1120; 65089-0050; 43598-304; 49884-418; 63629-8455; 63629-9310; 0591-2925; 38779-2936; 43647-568; 43742-1436; 73774-014; 76003-1083; 43742-1242; 0245-0871; 62332-552; 70700-112; 76420-685; 76420-687; 76420-699; 24979-130; 45802-610; 0051-8462; 64380-151; 68180-943; 69097-363; 0591-2363; 0603-7831; 0009-5020; 44132-006; 49452-7658; 64025-0010; 45802-281; 0245-0872; 0023-5992; 63629-2125; 64380-152; 66887-001; 0591-2114; 0591-2924; 0591-2926; 0591-3216; 0832-1121; 51927-0267; 70492-002; 76420-684; 0009-0074; 12875-8248; 22552-0009; 49452-7652; 60592-721; 60870-0251; 16714-967; 17139-562; 63629-2124; 68180-941; 44132-008; 48087-0113; 51552-0029; 42667-5511; 63481-183; 63629-2352; 69238-1013; 0591-3217; 0591-3524; 38779-0163; 38779-2598; 82393-113; 24979-078; 45802-366; 66887-004; 51552-0564; 62991-2150; 76420-686; 16714-969; 45802-754; 49884-510; 62332-488; 69339-158; 0591-2921; 49452-7657; 16714-968; 0023-5990
UNII 3XMK78S47O
Synonyms Testosterone | 17-beta-Hydroxy-4-Androsten-3-one | 17 beta Hydroxy 4 Androsten 3 one | Androtop | Histerone | Sterotate | Sustanon | Androderm | Testoderm | Testolin | Testopel | Testosterone Sulfate | AndroGel | 8-Isotestosterone | 8 Isotestosterone | 17-beta-Hydroxy-8 alpha-4-Androsten-3-one | 17 beta Hydroxy 8 alpha 4 Androsten 3 one | Andropatch | Testim
Chemical Information
Molecular Formula C19H28O2
CAS Registry Number 58-22-0
SMILES CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hepatobiliary disease09.01.08.003--Not Available
Leukoplakia23.01.06.002; 08.01.06.013--Not Available
Hyperlipidaemia14.08.03.0010.000591%
Renal impairment20.01.03.010--Not Available
Sinus disorder22.04.06.0020.000554%
Unevaluable event08.01.03.0510.002399%Not Available
Non-cardiac chest pain22.12.02.009; 08.01.08.0060.000091%
Peripheral arterial occlusive disease24.04.03.0100.000245%Not Available
Arterial occlusive disease24.04.02.0210.000727%Not Available
Chorioretinopathy06.09.01.0060.000364%Not Available
Implant site pain12.07.02.008; 08.02.02.0080.002745%Not Available
Application site induration08.02.01.014; 12.07.01.015--Not Available
Choroidal effusion06.09.01.0080.000091%Not Available
Application site exfoliation23.03.07.007; 12.07.01.022; 08.02.01.0220.000618%Not Available
Procedural pain12.02.05.007; 08.01.08.009--Not Available
Application site burn23.03.11.013; 08.02.01.038; 12.07.01.0380.000509%Not Available
Bronchial hyperreactivity22.03.01.016--Not Available
Thyroid cancer16.24.03.001; 05.02.05.0010.000091%Not Available
Gingival erythema07.09.13.006--Not Available
Oral disorder07.05.01.005--Not Available
Vulvovaginal burning sensation21.08.02.007--Not Available
Brain injury19.07.03.007; 17.11.01.0030.000364%Not Available
Androgenetic alopecia23.02.02.002; 05.05.04.001--Not Available
Brain stem stroke24.04.06.024; 17.08.01.0330.000182%Not Available
Pulmonary oil microembolism24.01.06.007; 22.06.02.007; 12.02.07.008--Not Available
Hypoxic-ischaemic encephalopathy24.04.06.021; 22.02.02.011; 17.13.02.0060.000182%Not Available
Sensitisation10.02.01.012; 08.01.05.0090.000309%Not Available
Korsakoff's syndrome19.20.05.002; 17.03.02.008; 14.12.02.007--Not Available
Prostatic dysplasia21.04.01.007--Not Available
Peripheral artery thrombosis24.01.02.0100.000318%Not Available
The 17th Page    First    Pre   17 18 19    Next   Last    Total 19 Pages